Found 334 matching trials
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
PHASE2The goal of this prospective study is to explore the safety and preliminary...
Location
Fudan University Shanghai Cancer Center
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
PHASE2This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Location
Multiple Locations
Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric Cancer
PHASE2Consistent with previous literature, the investigators postulate that a leu...
Location
Qilu Hospital of Shandong University
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer
PHASE2This is a single-arm, phase II study aiming to evaluate the feasibility and...
Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC
NAThe aim of this clinical trial is to find out whether Regorafenib and Sinti...
Location
The First People's Hospital of Changzhou
Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study
PHASE2Study Purpose: To evaluate the efficacy and safety of sintilimab in combina...
Location
Sun Yat-sen University Cancer Center
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
N/AHepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Location
Chinese PLA General hospital
The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution.
PHASE2Providing more theoretical basis for the prediction of the efficacy of adva...
Location
Department of Medical Oncology, Central Hospital of Yichang City, the First Clinical Medical College of Three Gorges University
A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.
PHASE2Recently, a number of clinical studies were carried out to evaluate the the...
Location
Multiple Locations
BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL
PHASE3This is a randomized, open-label, prospective, multicenter phase III superi...
Location
Fudan University Shanghai Cancer Center,